Screener
CONMED CNMD Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| authorized 500,000 shares; none outstanding | — | — |
| Common stock, par value $0.01 per share;100,000,000 shares authorized; 31,299,194 sharesissued in 2026 and 2025, respectively | 313 | 313 |
| Paid-in capital | 513,464 | 503,200 |
| Retained earnings | 625,665 | 588,766 |
| Accumulated other comprehensive loss | (43,372) | (46,295) |
| Less: 1,312,367 and 328,097 shares of common stock in treasury, at cost, in 2026 and 2025, respectively | (54,680) | (12,887) |
| Total shareholders’ equity | 1,041,390 | 1,033,097 |
| Total liabilities and shareholders’ equity | $2,300,306 | $2,325,749 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's treasury stock, shares (in shares)?
- CONMED (CNMD) reported treasury stock, shares (in shares) of $1.31M in Q2 2026.
- How has CONMED's treasury stock, shares (in shares) changed year-over-year?
- CONMED's treasury stock, shares (in shares) increased by 271.9% year-over-year, from $352.9K to $1.31M.
- What is the long-term trend for CONMED's treasury stock, shares (in shares)?
- Over 3 years (2022 to 2025), CONMED's treasury stock, shares (in shares) has grown at a -26.1% compound annual growth rate (CAGR), from $811.53K to $328.1K.
Ask your AI about CONMED's treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude